Related Experiment Video
Updated: Sep 4, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
The Epidemiology and Outcome of Pericardial Effusion in Hospitalized Children: A National Database Analysis
Jun Sasaki1, Prithvi Sendi2, Matthew T Hey3
1Division of Pediatric Critical Care Medicine and Pediatric Cardiology, Weill Cornell Medicine/NewYork-Presbyterian Komansky Children's Hospital, New York, NY.
Insights
Pediatric pericardial effusion is rare, affecting 0.1% of hospitalized children. Mortality risk is higher in younger patients with solid tumors or those needing drainage, but lower in older children with cardiac or rheumatologic conditions.
Area of Science:
- Pediatric Cardiology
- Pediatric Critical Care
- Pediatric Rheumatology
Background:
- Pericardial effusion (PE) is an understudied condition in pediatric hospitalizations.
- Understanding PE epidemiology and risk factors is crucial for improving patient outcomes.
Purpose of the Study:
- To determine the epidemiology of pericardial effusion in hospitalized children.
- To identify risk factors for pericardial effusion drainage and hospital mortality.
Main Methods:
- Retrospective analysis of the Kids' Inpatient Database 2016.
- Inclusion of pediatric patients (neonates to 20 years) with pericardial effusion.
- Statistical analysis of drainage rates and mortality risks based on diagnoses and interventions.
Main Results:
- Pericardial effusion occurred in 0.1% of pediatric discharges (6,417 cases).
- Highest prevalence was observed in adolescents (13-20 years).
- Drainage was performed in 12.3% of cases; mortality was 6.8% overall and 10.9% post-drainage.
Conclusions:
- Mortality risk for pediatric pericardial effusion is elevated in younger children, those with solid tumors, and following drainage.
- Lower mortality risk is associated with cardiac structural or rheumatologic diagnoses and older age groups.
Objectives:
To describe the epidemiology of pericardial effusion in hospitalized children and evaluate risk factors associated with the drainage of pericardial effusion and hospital mortality.
Study Design:
A retrospective study of a national pediatric discharge database.
Results:
We analyzed hospitalized pediatric patients from the neonatal age through 20 years in the Kids' Inpatient Database 2016, extracting the cases of pericardial effusion. Of the 6 266 285 discharged patients recorded, 6417 (0.1%) were diagnosed with pericardial effusion, with the highest prevalence of 2153 patients in teens (13-20 years of age). Pericardial effusion was drained in 792 (12.3%), and the adjusted risk of pericardial drainage was statistically low with rheumatologic diagnosis (OR, 0.485; 95% CI, 0.358-0.657, P < .001). The overall mortality in children with pericardial effusion was 6.8% and 10.9% of those who required pericardial effusion drainage (P < .001). The adjusted risk of mortality was statistically high with solid organ tumor (OR, 1.538; 95% CI, 1.056-2.239, P = .025) and pericardial drainage (OR, 1.430; 95% CI, 1.067-1.915, P = .017) and low in all other age groups compared with neonates, those with cardiac structural diagnosis (OR, 0.322; 95% CI, 0.212-0.489, P < .001), and those with rheumatologic diagnosis (OR, 0.531; 95% CI, 0.334-0.846, P = .008).
Conclusion:
The risk of mortality in hospitalized children with pericardial effusion was higher in younger children with solid organ tumors and those who required pericardial effusion drainage. In contrast, it was lower in older children with cardiac or rheumatologic diagnoses.
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
Pericarditis I: Introduction
Pericarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

